Growth Metrics

Corcept Therapeutics (CORT) Profit After Tax (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Corcept Therapeutics 7.26 Bn 6.92 Bn 162.02 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -230.77%
Dec 31, 2025 23.49%
Sep 30, 2025 -44.04%
Jun 30, 2025 71.07%
Mar 31, 2025 -33.17%
Dec 31, 2024 -34.88%
Sep 30, 2024 33.04%
Jun 30, 2024 27.83%
Mar 31, 2024 -11.46%
Dec 31, 2023 -0.07%
Sep 30, 2023 13.99%
Jun 30, 2023 73.36%
Mar 31, 2023 -4.35%
Dec 31, 2022 -52.03%
Sep 30, 2022 26.25%
Jun 30, 2022 20.24%
Mar 31, 2022 -28.88%
Dec 31, 2021 5.19%
Sep 30, 2021 14.89%
Jun 30, 2021 13.03%
Mar 31, 2021 -9.73%
Dec 31, 2020 20.20%
Sep 30, 2020 -23.66%
Jun 30, 2020 -5.78%
Mar 31, 2020 2.33%
Dec 31, 2019 11.55%
Sep 30, 2019 30.49%
Jun 30, 2019 10.46%
Mar 31, 2019 -16.97%
Dec 31, 2018 24.01%
Sep 30, 2018 -2.47%
Jun 30, 2018 4.22%
Mar 31, 2018 -82.24%
Dec 31, 2017 614.76%
Sep 30, 2017 8.78%
Jun 30, 2017 188.22%
Mar 31, 2017 -4.55%
Dec 31, 2016 77.83%
Sep 30, 2016 164.59%
Jun 30, 2016 5,242.11%
Mar 31, 2016 -101.98%
Dec 31, 2015 259.57%
Sep 30, 2015 68.96%
Jun 30, 2015 59.92%
Mar 31, 2015 -24.01%
Dec 31, 2014 35.15%
Sep 30, 2014 20.47%
Jun 30, 2014 45.79%
Mar 31, 2014 -25.22%
Dec 31, 2013 -2.00%
Sep 30, 2013 8.33%
Jun 30, 2013 1.55%
Mar 31, 2013 -8.63%
Dec 31, 2012 -34.14%
Sep 30, 2012 -9.16%
Jun 30, 2012 31.15%
Mar 31, 2012 -11.05%
Dec 31, 2011 -54.41%
Sep 30, 2011 27.55%
Jun 30, 2011 -25.08%
Mar 31, 2011 -0.11%
Dec 31, 2010 0.15%
Sep 30, 2010 -24.74%